Diabetes and COVID-19 present a complex interplay with significant implications for patient management and outcomes. Individuals with diabetes, particularly those with poorly controlled blood glucose levels, are at increased risk of severe complications from COVID-19, including higher rates of hospitalization and mortality. The virus can exacerbate diabetes by causing acute hyperglycemia and insulin resistance. Conversely, managing diabetes during the pandemic has been challenging due to disruptions in routine care and potential medication shortages. Effective management includes rigorous glucose monitoring, maintaining a healthy diet, and adhering to prescribed treatments. Vaccination and preventive measures are also crucial to reduce the risk of severe outcomes.
